Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | DRD1 | P21728 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CCR6 | P51684 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.42 |
| ▸ | BAX | Q07812 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL27369268 | 0.88 | LTA4H (0.54) | MEN1KMT2AALOX15GFERADAM17 | |
| SCHEMBL11065049 | 0.86 | DRD1 (0.56) | MEN1KMT2AALOX15GFERADAM17 | |
| SCHEMBL3732313 | 0.80 | MEN1 (0.46) | MEN1KMT2AALOX15ESR2ESR1 | |
| SCHEMBL22816814 | 0.80 | CYP1A2 (0.46) | MEN1KMT2AALOX15ESR2ESR1 | |
| SCHEMBL14214496 | 0.80 | ESR2 (0.47) | MEN1KMT2AALOX15ESR2ESR1 | |
| SCHEMBL13264261 | 0.78 | DRD1 (0.68) | MEN1KMT2AALOX15GFERADAM17 | |
| SCHEMBL9143036 | 0.77 | ESR2 (0.46) | MEN1KMT2AESR2ESR1LTA4H | |
| SCHEMBL29431683 | 0.77 | ESR1 (0.49) | MEN1KMT2AALOX15ESR2ESR1 | |
| SCHEMBL8266849 | 0.76 | ALDH1A1 (0.49) | MEN1KMT2AALOX15GFERADAM17 | |
| SCHEMBL9605425 | 0.75 | PTGS1 (0.59) | MEN1KMT2AALOX15ESR1GFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0096263-B1 | DIFLUOROMETHOXYPHENYLTHIOPHOSPHORIC-ACID ESTERS | BASF Aktiengesellschaft (DE) | 1985-12-11 | — | — | EP | claimed |
| US-20260085077-A1 | HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2026-03-26 | — | — | US | disclosed |
| EP-3704094-B1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260022100-A1 | NAV1.8 INHIBITOR | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) | 2026-01-22 | — | — | US | disclosed |
| US-20260001861-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS FOR INHIBITING NAV1.8 | LIEBER INST INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250346600-A1 | TRICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. | 2025-11-13 | — | — | US | disclosed |
| US-12435040-B2 | 1,3-substituted cyclobutyl derivatives and uses thereof | BAUSCH + LOMB IRELAND LIMITED (IE) | 2025-10-07 | — | — | US | disclosed |
| EP-4605076-A1 | PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3 (PNPLA3) MODIFIERS | Pfizer Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| EP-4604955-A1 | USE OF PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3 COMPOUNDS | Pfizer Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| EP-3351533-B1 | BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME | KAKEN PHARMA CO LTD (JP) | 2025-07-23 | — | — | EP | disclosed |
| EP-0203312-B1 | PHOSPHAZENE BASED FUNCTIONAL FLUID COMPOSITIONS | GE CHEMICALS, INC. (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0381728-A1 | DIFLUOROMETHYL COMPOUNDS. | MERCK PATENT GMBH (DE) | 1990-08-16 | — | — | EP | disclosed |
| WO-1990001056-A1 | DIFLUOROMETHYL COMPOUNDS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-02-08 | — | — | WO | disclosed |
| EP-0203312-A2 | Phosphazene based functional fluid compositions | GE CHEMICALS, INC. (US) | 1986-12-03 | — | — | EP | disclosed |
| US-4601843-A | Phosphazene based functional fluid compositions | BORG-WARNER CHEMICALS, INC. (US) | 1986-07-22 | — | — | US | disclosed |
| EP-0048136-B1 | PROCESS FOR PREPARING ALPHA-AROMATIC GROUP SUBSTITUTED ALKANOIC ACIDS OR ESTERS THEREOF | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1986-06-11 | — | — | EP | disclosed |
| EP-0096263-B1 | DIFLUOROMETHOXYPHENYLTHIOPHOSPHORIC-ACID ESTERS | BASF Aktiengesellschaft (DE) | 1985-12-11 | — | — | EP | disclosed |
| EP-0083010-B1 | DIETHERS OF M- OR P-HYDROXYPHENOLS AND PROCESS FOR PREPARING DIETHERS OR MONOETHERS OF M- OR P-HYDROXYPHENOLS | BASF Aktiengesellschaft (DE) | 1985-12-04 | — | — | EP | disclosed |
| US-4512984-A | Difluoromethoxyphenyl thiophosphates as pesticides | BASF AKTIENGESELLSCHAFT (DE) | 1985-04-23 | — | — | US | disclosed |
| EP-0083010-A1 | Diethers of m- or p-hydroxyphenols and process for preparing diethers or monoethers of m- or p-hydroxyphenols | BASF Aktiengesellschaft (DE) | 1983-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435040-B2 | 1,3-substituted cyclobutyl derivatives and uses thereof | TRPV1, TRPV3, TRPV2 | MEN1 4212/4885KMT2A 4773/4885ALOX15 225/4885 |
| US-20260022100-A1 | NAV1.8 INHIBITOR | SCN8A, SCN1B, SCN1A | MEN1 3045/4885KMT2A 3333/4885ALOX15 3632/4885 |
| US-20260001861-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS FOR INHIBITING NAV1.8 | SCN8A, SCN1A, SCN1B | MEN1 3364/4885KMT2A 2792/4885ALOX15 2876/4885 |
| US-20260085077-A1 | HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS | TYK2, JAK1, JAK3 | MEN1 4831/4885KMT2A 1977/4885ALOX15 1687/4885 |
| US-20250346600-A1 | TRICYCLIC DERIVATIVES AND RELATED USES | WRN, RECQL, BLM | MEN1 1187/4885KMT2A 2611/4885ALOX15 3527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.